tiprankstipranks
Trending News
More News >
Greenland Mines (GRML)
NASDAQ:GRML
US Market

Greenland Mines (GRML) Price & Analysis

Compare
336 Followers

GRML Stock Chart & Stats

$0.37
-$0.02(-3.27%)
At close: 4:00 PM EST
$0.37
-$0.02(-3.27%)

GRML FAQ

What was Greenland Mines’s price range in the past 12 months?
Greenland Mines lowest stock price was $0.11 and its highest was $3.91 in the past 12 months.
    What is Greenland Mines’s market cap?
    Greenland Mines’s market cap is $27.21M.
      When is Greenland Mines’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Greenland Mines’s earnings last quarter?
      Currently, no data Available
      Is Greenland Mines overvalued?
      According to Wall Street analysts Greenland Mines’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Greenland Mines pay dividends?
        Greenland Mines does not currently pay dividends.
        What is Greenland Mines’s EPS estimate?
        Greenland Mines’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Greenland Mines have?
        Greenland Mines has 73,536,720 shares outstanding.
          What happened to Greenland Mines’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Greenland Mines?
          Currently, no hedge funds are holding shares in GRML
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            Greenland Mines

            Greenland Mines Ltd. engages in the provision of new therapies to treat neurodegenerative diseases. It offers cell and gene therapy. The company was founded by Joseph Sinkule on August 2, 2004 and is headquartered in Omaha, NE.
            Similar Stocks
            Company
            Price & Change
            Follow
            ProMIS Neurosciences
            Annovis Bio
            Lantern Pharma
            Neurosense Therapeutics Ltd.

            Ownership Overview

            17.03%0.90%0.86%80.63%
            17.03% Insiders
            0.86% Other Institutional Investors
            80.63% Public Companies and
            Individual Investors

            Options Prices

            Currently, No data available
            ---
            Popular Stocks